These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 36146501)

  • 1. Dynamic Changes in Hepatitis A Immunity in Regions with Different Vaccination Strategies and Different Vaccination Coverage.
    Kyuregyan KK; Lopatukhina MA; Asadi Mobarkhan FA; Kichatova VS; Potemkin IA; Isaeva OV; Karlsen AA; Malinnikova EY; Kaira AN; Kozhanova TV; Manuylov VA; Mazunina EP; Bykonia EN; Kleymenov DA; Ignateva ME; Trotsenko OE; Kuznetsova AV; Saryglar AA; Oorzhak ND; Romanenko VV; Mikhailov MI
    Vaccines (Basel); 2022 Aug; 10(9):. PubMed ID: 36146501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling hepatitis A epidemiological profiles and estimating the pediatric vaccination threshold in the Russian Federation.
    Taratorkin FF; Karlsen AA; Kyuregyan KK; Lopatukhina MA; Khankishiyev F; Manuylov VA; Akimkin VG; Mikhailov MI
    Front Public Health; 2024; 12():1371996. PubMed ID: 38993707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence and Shifting Endemicities of Hepatitis A Virus Infection in Two Different Geographical Areas in the Philippines.
    Carlos JC; Quinones VMT; Adversario MPL; Nailes JM; Songco JC; Garcia DR; Cacayorin MG; Cero MPV; Benedicto-Delfin MPA; Blanco MCC; Natividad NS; Bernabe JD; Chacon HCT; Ascue RAC; Paggao JNK; Comendador LOP; Hernandez-Suarez G; Guzman-Holst A
    Infect Dis Ther; 2024 May; 13(5):1019-1035. PubMed ID: 38578515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroprevalence of hepatitis A virus among people born before and after implementation of universal vaccination in Argentina.
    Flichman DM; Ridruejo E; Grosso F; Ramírez E; Martínez AP; Baré P; Di Lello FA
    Infect Dis (Lond); 2024 Jun; ():1-8. PubMed ID: 38913347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of the effect of mass vaccination against hepatitis B in the Russian Federation].
    Klushkina VV; Kozhanova TV; Bazhazhina PG; Popova OE; Il'chenko LIu; Kiuregian KK; Mikhaĭlov MI
    Zh Mikrobiol Epidemiol Immunobiol; 2012; (5):42-8. PubMed ID: 23163035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determining Herd Immunity Thresholds for Hepatitis A Virus Transmission to Inform Vaccination Strategies Among People Who Inject Drugs in 16 US States.
    Yang J; Lo NC; Dankwa EA; Donnelly CA; Gupta R; Montgomery MP; Weng MK; Martin NK
    Clin Infect Dis; 2024 Apr; 78(4):976-982. PubMed ID: 37738564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunity to Hepatitis-A virus: A nationwide population-based seroprevalence study from Iran.
    Lankarani KB; Honarvar B; Molavi Vardanjani H; Kharmandar A; Gouya MM; Zahraei SM; Baneshi MR; Ali-Akbarpour M; Kazemi M; Seif M; Fard SAZ; Emami A
    Vaccine; 2020 Oct; 38(45):7100-7107. PubMed ID: 32917416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis A vaccination and its immunological and epidemiological long-term effects - a review of the evidence.
    Herzog C; Van Herck K; Van Damme P
    Hum Vaccin Immunother; 2021 May; 17(5):1496-1519. PubMed ID: 33325760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of universal mass vaccination with monovalent inactivated hepatitis A vaccines - A systematic review.
    Stuurman AL; Marano C; Bunge EM; De Moerlooze L; Shouval D
    Hum Vaccin Immunother; 2017 Mar; 13(3):724-736. PubMed ID: 27786671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The seroprevalence rate, vaccination rate and seroconversion rate of hepatitis A in central region of Korea].
    Yun SW; Lee WK; Cho SY; Moon SH; Shin HD; Yun SY; Kim SB; Shin JE; Kim HJ; Song IH; Lee KS; Lee JH
    Korean J Gastroenterol; 2011 Mar; 57(3):166-72. PubMed ID: 21519164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health economic assessment of universal immunization of toddlers against Hepatitis A Virus (HAV) in Mexico.
    Carlos F; Gómez JA; Anaya P; Romano-Mazzotti L
    Hum Vaccin Immunother; 2016; 12(1):52-63. PubMed ID: 26503702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Universal Single-Dose Vaccination against Hepatitis A in Children in a Region of High Endemicity.
    Mikhailov MI; Lopatukhina MA; Asadi Mobarhan FA; Ilchenko LY; Kozhanova TV; Isaeva OV; Karlsen AA; Potemkin IA; Kichatova VS; Saryglar AA; Oorzhak ND; Kyuregyan KK
    Vaccines (Basel); 2020 Dec; 8(4):. PubMed ID: 33419299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changing epidemiological characteristics of Hepatitis A and warning of Anti-HAV immunity in Beijing, China: a comparison of prevalence from 1990 to 2017.
    Wang H; Gao P; Chen W; Bai S; Lv M; Ji W; Pang X; Wu J
    Hum Vaccin Immunother; 2019; 15(2):420-425. PubMed ID: 30260275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreasing immunity to hepatitis A virus infection among US adults: Findings from the National Health and Nutrition Examination Survey (NHANES), 1999-2012.
    Klevens RM; Denniston MM; Jiles-Chapman RB; Murphy TV
    Vaccine; 2015 Nov; 33(46):6192-8. PubMed ID: 26476364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effectiveness and limitation of the national childhood hepatitis A vaccination program in the Republic of Korea: Findings from the Korean National Health and Nutrition Examination Survey (KNHANES), 2015.
    Lim J; Kim K; Choi S; Park SM
    PLoS One; 2017; 12(12):e0189210. PubMed ID: 29220416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of routine catch-up hepatitis a vaccination in the United States: Dynamic transmission modeling study.
    Elbasha EH; Choi Y; Daniels V; Goveia MG
    Vaccine; 2021 Oct; 39(42):6315-6321. PubMed ID: 34538694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010.
    Naidu L; Chiu C; Habig A; Lowbridge C; Jayasinghe S; Wang H; McIntyre P; Menzies R
    Commun Dis Intell Q Rep; 2013 Dec; 37 Suppl():S1-95. PubMed ID: 24410428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The chronological changes in the seroprevalence of anti-hepatitis A virus IgG from 2005 to 2019: Experience at four centers in the capital area of South Korea.
    Lim DH; Sohn W; Jeong JY; Oh H; Lee JG; Yoon EL; Kim TY; Nam S; Sohn JH
    Medicine (Baltimore); 2022 Dec; 101(48):e31639. PubMed ID: 36482612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis A in Puglia (South Italy) after 10 years of universal vaccination: need for strict monitoring and catch-up vaccination.
    Chironna M; Prato R; Sallustio A; Martinelli D; Tafuri S; Quarto M; Germinario C
    BMC Infect Dis; 2012 Oct; 12():271. PubMed ID: 23098290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in seroprevalence of hepatitis A after the implementation of universal childhood vaccination in Shandong Province, China: A comparison between 2006 and 2014.
    Yan BY; Lv JJ; Liu JY; Feng Y; Wu WL; Xu AQ; Zhang L
    Int J Infect Dis; 2019 May; 82():129-134. PubMed ID: 30862519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.